HOUSTON, Jan. 6, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro-hospitals in 11 states and primary care-centric, risk-bearing physician networks, today announced that it will be presenting at the industry's largest healthcare investment symposium— the 43rd Annual J.P. Morgan Healthcare Conference. This event will take place from January 13th to 16th in San Francisco, Califo ...

NUTEX HEALTH CONTINUES TO EXPAND ITS NATIONAL FOOTPRINT WITH ITS THIRD HOSPITAL OPENING IN 2024HOUSTON, Nov. 18, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 23 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in ten states and primary care-centric, risk-bearing physician networks, today announced the opening of Milwaukee ER & Hospital, located at 1751 W Layton Ave, Mil ...

Financial Data and Key Metrics Changes - Total revenue for Q3 2024 was reported at $78.8 million, a significant increase of 26% compared to $62.7 million in Q3 2023 [6][25] - Net loss attributable to Nutex Health was $8.8 million in Q3 2024, compared to a net loss of $5.5 million in Q3 2023, which included a $6.7 million noncash loss on warrant liability and a $2 million noncash stock-based compensation expense [7][36] - Adjusted EBITDA for Q3 2024 was $13.5 million, a remarkable increase of 938% from $1.3 million in Q3 2023 [8][37] - Net cash from operating activities increased to $23.1 million in Q3 2024 from $3 million in the same period last year, marking a 670% increase [8][45] Business Line Data and Key Metrics Changes - The Hospital division reported 41,668 visits in Q3 2024, reflecting an 11.3% increase over the same quarter last year, with mature hospitals showing a 3.8% increase [9][26] - The Population Health division experienced a revenue decrease to $7.1 million in Q3 2024 from $8.1 million in Q3 2023, primarily due to the divestiture of two small entities [26][52] Market Data and Key Metrics Changes - Mature hospitals contributed to a revenue increase of 20.7% in Q3 2024 compared to Q3 2023 [25] - Total facility level operating costs represented 72.2% of total revenue in Q3 2024, down from 88.7% in Q3 2023, leading to a gross profit of $21.9 million [28] Company Strategy and Development Direction - The company plans to continue de novo expansions, aiming to open 2 to 4 new hospitals per year, with two new facilities already opened in 2024 [13][14] - There is a focus on expanding services in mature hospitals to meet evolving patient needs, including adding new specialties [15][16] - The company is committed to improving operational efficiency and enhancing patient care through advanced technologies and community engagement [19][20][21] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the trajectory of the company, emphasizing the importance of adapting to the changing healthcare landscape [22] - The company is focused on obtaining better reimbursements from insurers and is actively engaging in the No Surprises Act arbitration process [17][18] Other Important Information - The company reported a total long-term debt of $26.8 million, which remains low compared to the previous year [8] - The balance sheet showed cash and cash equivalents of $46.9 million at the end of September 2024, up 113.2% from $22 million at the end of 2023 [45] Q&A Session Summary Question: How is the company seeing patient visits in the fourth quarter? - Management indicated that the fourth quarter typically experiences higher volume due to flu season, although this year has been warmer than usual [72][73] Question: What is the outlook for CapEx going forward? - The CFO noted that CapEx is expected to increase as new facilities open, with a consistent plan of 2 to 4 openings per year [75][76] Question: What progress has been made with NSA arbitrations? - Management reported a positive trend in arbitration outcomes, with a win rate of approximately 70% to 80% expected based on industry data [79][80] Question: What percentage of claims are being put into arbitration? - Management stated that between 60% to 80% of claims are being processed through the entire negotiation and arbitration process [81] Question: What new services are being introduced in Q4 or 2025? - Management is exploring new service lines based on community needs, including behavioral health and personal injury services [94][95] Question: What is the greatest opportunity for further cost structure improvement? - Management sees all three areas of labor costs, supply chain management, and contract services as significant opportunities for improvement [97] Question: What progress has been made in removing variable interest entities from the balance sheet? - Management confirmed progress in discussions with lenders to remove two remaining variable interest entities by the end of the year [101]

Revenue and Growth - Total revenue for the first nine months of 2024 was $222.3 million, an increase of 25% compared to $178.0 million for the same period in 2023[1] - Total revenue for the three months ended September 30, 2024, was $78,794,869, a 25.6% increase from $62,722,972 in the same period of 2023[11] - The four de-novo hospitals opened in 2023 are contributing to strong year-over-year growth in revenue and patient volume[6] Operating Performance - Operating income for the first nine months of 2024 was $54.7 million, a significant increase of 159% from $21.1 million in the same period in 2023[1] - Adjusted EBITDA for the third quarter of 2024 was $13.5 million, representing a 938% increase from $1.3 million in the third quarter of 2023[2] - Operating income for the three months ended September 30, 2024, was $9,662,745, compared to a loss of $(821,226) in the same period of 2023[11] - Adjusted EBITDA attributable to Nutex Health Inc. for 2024 was $13,463,592, a substantial increase from $1,279,193 in 2023[16] Net Loss and Financial Position - Net loss attributable to Nutex Health for the three months ended September 30, 2024, was $8.8 million, compared to a net loss of $5.5 million for the same period in 2023[2] - Net loss attributable to Nutex Health Inc. for 2024 was $(8,788,313), compared to $(5,542,391) in 2023, indicating a significant increase in losses[16] - Cash and cash equivalents at the end of the period were $46,909,281, up from $26,826,733 at the end of September 2023[12] - The company reported a net cash from operating activities of $23.1 million for the first nine months of 2024[3] - Net cash from operating activities for the nine months ended September 30, 2024, was $23,100,345, compared to $3,032,670 in the same period of 2023[12] Expenses and Liabilities - Total operating costs and expenses for the three months ended September 30, 2024, were $56,878,055, slightly up from $55,656,759 in the prior year[11] - The company reported a loss on warrant liability of $6,733,552 for the three months ended September 30, 2024[11] - Interest expense, net, increased to $5,381,040 in 2024 from $4,098,179 in 2023, reflecting higher borrowing costs[16] - Stock-based compensation expense rose to $1,963,518 in 2024 from $49,167 in 2023, indicating increased equity compensation[16] Hospital Division and Operations - Hospital division visits reached 122,944 for the first nine months of 2024, up 20% from 102,798 visits in the same period in 2023[1] - Total visits from the Hospital Division for the third quarter of 2024 were 41,668, an increase of 11.3% from 37,443 visits in the third quarter of 2023[2] - The Hospital Division operates 22 facilities across ten states, focusing on innovative healthcare models[17] Future Outlook and Risks - The company plans to continue growing its hospital and population health divisions responsibly to drive shareholder value[6] - The company anticipates continued growth but faces risks related to execution of its growth strategy and economic conditions[18] - Future financial performance may be adversely affected by various risks, including competition and regulatory changes[18]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41346 NUTEX HEALTH INC. (Exact name of registrant as specified in its charter) | --- | --- | --- | |----- ...

HOUSTON, Nov. 1, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 10 states and primary care-centric, risk-bearing physician networks, today announced that it will release financial results for the third quarter ended September 30, 2024 after the close of the stock market on Thursday, November 7, 2024. The Company will discuss those results on a conference call o ...

Shares of Nutex Health Inc (NUTX, Financial) surged 5.48% in mid-day trading on Oct 2. The stock reached an intraday high of $21.86, before settling at $21.69, up from its previous close of $20.56. This places NUTX 51.81% below its 52-week high of $45.00 and 421.29% above its 52-week low of $4.16. Trading volume was 14,294 shares, 17.6% of the average daily volume of 81,254. Wall Street Analysts Forecast Based on the one-year price targets offered by 2 analysts, the average target price for Nutex Health Inc ...

HOUSTON, Sept. 30, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 10 states and primary care-centric, risk-bearing physician networks, today announced that Nutex Health hospitals have won multiple community-driven awards and accolades in the third quarter of 2024, reflecting the staff's commitment to excellence. All six of the hospital's Physicians and the Chie ...

Nutex Health expands its footprint with Post Falls ER & Hospital on the border of Idaho and Washington, serving patients from both states. POST FALLS, Idaho, Aug. 26, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 10 states and primary care-centric, risk-bearing physician networks, today announced the opening of Post Falls ER & Hospital, located at 497 S Beck Road in Post ...

Nutex Health (NASDAQ:NUTX) Q2 2024 Earnings Conference Call August 9, 2024 10:00 AM ET Company Participants Jennifer Rodriguez - Investor Relations Manager Tom Vo - Chairman and Chief Executive Officer Jon Bates - Chief Financial Officer Warren Hosseinion – President Josh DeTillio – Chief Operating Office Conference Call Participants Bill Sutherland - The Benchmark Company Operator Greetings, and welcome to Nutex Health Second Quarter 2024 Financial Results Conference Call. At this time, all participants ar ...